Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

American Well Corp Cl A (NY: AMWL )

0.5426 -0.0097 (-1.76%)
Official Closing Price Updated: 7:00 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about American Well Corp Cl A

< Previous 1 2 3 Next >
Amwell® to Report First Quarter 2024 Operating Results May 1
From Amwell
Via GlobeNewswire
Amwell Receives Continued Listing Standard Notice From NYSE
Amwell’s Class A Common Stock continues to trade on the NYSE 
From Amwell
Via GlobeNewswire
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Amwell clients to present on automated care, Converge platform integration 
From Amwell
Via GlobeNewswire
Hims & Hers Stock Rises On Stimulating Earnings Growth
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience 
Via MarketBeat
Amwell Names Cynthia Horner, M.D., Chief Medical Officer
Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits 
From Amwell
Via GlobeNewswire
Amwell Expands Presence in Australia with Amplar Health Partnership
Amplar Health to leverage Amwell’s digital care technology for chronic disease prevention programs 
From Amwell
Via GlobeNewswire
Amwell to Participate in Upcoming Investor Conference
From Amwell
Via GlobeNewswire
Amwell Executives to Take the Stage at ViVE 2024
Company leaders to moderate or speak at sessions on virtual care delivery, GLP-1s 
From Amwell
Via GlobeNewswire
Amwell Announces Results for Fourth Quarter and Full Year 2023
From Amwell
Via GlobeNewswire
Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14
From Amwell
Via GlobeNewswire
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
Weiler brings 20+ years of strategic and commercial leadership experience to the Axogen, Inc. Board of Directors 
From Axogen, Inc.
Via GlobeNewswire
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
3 more tax-loss selling buy opportunities
This is the season when tax-loss selling occurs; here are three tax-loss selling buy opportunities for risk-tolerant investors and speculators to consider 
Via MarketBeat
Amwell Announces Results for Third Quarter 2023
From Amwell
Via Business Wire
Amwell to Participate in Upcoming Investor Conferences
From Amwell
Via Business Wire
U.S. Defense Health Agency selects Amwell® and Leidos to power the Digital First initiative for the U.S. Military Health System
From Amwell
Via Business Wire
Amwell to Report Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, Nov. 1, 2023
From Amwell
Via Business Wire
Amwell® Partners With Discovery Health to Bring First-of-its-Kind Digital Mental Health Benefit to South Africa
From American Well Corporation
Via Business Wire
Nestlé Health Science Collaborates With Amwell® to Improve Nutrition Outcomes in Healthcare
From Amwell
Via Business Wire
Amwell® to Participate in Key HLTH 2023 Engagements
From Amwell
Via Business Wire
Media Advisory: Amwell® and Northwell Health to Lead AI and Automation Roundtable at Becker’s Health IT Conference
From Amwell
Via Business Wire
Health Gorilla and Amwell Announce Expanded Digital Diagnostic Lab Ordering for Clinicians
From Amwell
Via Business Wire
Three Amwell® Health System Clients to Lead Hybrid Care Panel at Oracle Health Conference
From Amwell
Via Business Wire
OSF HealthCare Reduces Rates of Depression and Anxiety by Over 50% Using the Amwell® Platform
From Amwell
Via Business Wire
Amwell to Participate in Upcoming Investor Conferences
From Amwell
Via Business Wire
Amwell Announces Results for Second Quarter 2023
From Amwell
Via Business Wire
Amwell to Report Second Quarter 2023 Operating Results and Host Conference Call on Wed., Aug. 2, 2023
From Amwell
Via Business Wire
Amwell Survey Identifies Workers’ Top Barriers to Accessing Mental Health Benefits
From Amwell
Via Business Wire
DarioHealth is an AI-Powered Digital Therapeutics Play
DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.